Functional Validation of Glycolytic Enzymes (HK2 / PKM2 / LDHA)

Three enzymes, three reasons a knockout may not change flux.

The Problem With "Knock Out the Enzyme, Measure Glycolysis"

The experiment looks decisive and is usually ambiguous, for three reasons that apply differently to each enzyme.

ReasonHow it appearsHow to test it
Isoenzyme compensationFlux unchanged after knockoutMeasure paralog expression; double knockout
Non-catalytic functionPhenotype changes while flux does notCatalytically dead rescue; localisation assay
Enzyme not controlling fluxFlux unchanged but substrate or product pools shiftPerturb substrate supply; measure control by titration

Important distinction. A null result from a knockout supports two very different conclusions: that the enzyme is dispensable for the measured flux, or that the enzyme was not the step being measured. Titrating substrate supply distinguishes them: if flux rises with substrate in the knockout as in the control, the enzyme was not limiting.

Part 1 — HK2 (and the Hexokinase Family)

FeatureDetailConsequence for validation
FamilyHK1, HK2, HK3, HK4 (glucokinase) with different tissue distributionHK2 knockout in a line expressing HK1 may show little change
Mitochondrial associationHK2 binds VDAC at the outer membraneDetachment changes both glycolysis and apoptosis sensitivity
ProductGlucose-6-phosphateFeeds glycolysis, PPP and glycogen; a change redistributes among three routes
RegulationInhibited by G6P; induced by HIF1A and MYCExpression change is not flux change

What an HK2 knockout can establish. In a line where HK1 is low, HK2 loss reduces glucose-6-phosphate production, and if glucose uptake also falls, the knockout has changed the entry step. That is a statement about hexokinase capacity.

What it cannot establish. That glycolytic flux fell, unless flux is measured: G6P can be maintained by glycogenolysis, and glucose-6-phosphatase activity (where present) can recycle. In lines with HK1 compensation, the knockout may change only the proportion of hexokinase activity that is mitochondrial.

Design note. Report HK1, HK2 and HK3 protein levels alongside the knockout. The most common review question about an HK2 paper is whether the paralog was measured.

Part 2 — PKM2 (and the Splicing Question)

PKM2 is the most frequently over-interpreted glycolytic enzyme, because it has three separable properties.

PropertyWhat it meansHow to test
Pyruvate kinase activityConverts PEP to pyruvate, generating ATPEnzymatic assay on lysate; lactate production
Isoform choicePKM1 versus PKM2 from alternative splicing of PKMIsoform-specific primers or antibodies
Non-catalytic functionsNuclear localisation, transcriptional co-activation, protein interactionsCatalytically dead mutant; nuclear fraction

Caveat on PKM2 "knockout" designs. Standard knockouts of PKM remove both isoforms, which is often lethal or selects for adaptation, and isoform-specific effects cannot be attributed. A PKM2-specific exon-skipping design, or an isoform-swap (PKM2 to PKM1), is more informative and is the design that supports a claim about the isoform rather than about the gene.

Caveat on the tetramer–dimer story. The idea that PKM2 exists in a low-activity dimer that favours biosynthesis is widely cited and condition-dependent. Demonstrating it requires measuring the oligomeric state in cells, not inferring it from a proliferation phenotype; the available methods (crosslinking, native PAGE, and specific probes) each have artefacts, and the intracellular state is debated.

Design note. If the claim involves a nuclear function, a catalytically inactive mutant that still localises to the nucleus is the key control. Phosphoenolpyruvate or serine supplementation tests whether the phenotype is explained by metabolite supply rather than by the protein.

Part 3 — LDHA (and the Redox Constraint)

LDHA converts pyruvate to lactate while regenerating NAD⁺. Its knockout is the cleanest test of the lactate route and the least clean test of "glycolysis".

ReadoutExpected after LDHA knockoutInterpretation
Lactate releaseFalls markedlyThe route was used
Glucose consumptionOften falls, sometimes risesNAD⁺ regeneration is now limiting, or the cell adapts
OCROften risesPyruvate is diverted to mitochondria, if capacity allows
NAD⁺/NADH (bulk)May be unchangedCompartment-specific pools are averaged
Growth in hypoxiaTypically impairedThe route matters when oxidation is limited

Important distinction. LDHA loss is a redox perturbation as much as a carbon perturbation. In cells with sufficient respiratory capacity and an active malate–aspartate or glycerol phosphate shuttle, pyruvate can be oxidised and NAD⁺ regenerated mitochondrially; in cells without that capacity, glycolysis arrests at GAPDH. The same knockout therefore produces different phenotypes for reasons that have nothing to do with lactate.

Design note. The informative companion experiment is a pyruvate or an NAD⁺ precursor rescue: if pyruvate restores growth without restoring lactate, the limitation was redox or carbon, not lactate itself.

Part 4 — The Rescue That Separates Catalysis From Scaffolding

For all three enzymes, the single most informative control is a rescue with a mutant that cannot catalyse but is otherwise intact.

Rescue constructRestoresEstablishes
Wild-type cDNAFlux and phenotypeThe phenotype is due to the gene
Catalytically dead mutantLocalisation, interactions, protein levelThe phenotype requires catalysis
Catalytically dead mutant that fails to localiseNeitherThe localisation signal, not catalysis, was required
Isoform swap (for PKM)Catalysis with the other isoformThe isoform-specific property matters

Reporting expression level, localisation and stability of each rescue construct is part of the control, not an optional extra. A catalytically dead mutant that is poorly expressed will produce a "catalysis is required" conclusion for the wrong reason.

Part 5 — Three Levels of Evidence for an Enzyme Claim

LevelClaimMinimum evidenceWhat does not count
ExpressionThe enzyme is present or inducedProtein, with isoform resolutionmRNA alone
FluxThe enzyme step limits fluxTitration, or flux measurement before and after perturbationEnzyme activity in lysate alone
DependenceThe step is required for a phenotypeKnockout plus rescue, under the relevant constraintGrowth correlation at one condition

Enzyme activity measured in a lysate sits between the first two levels and is frequently reported as the second. A lysate assay measures capacity under optimal substrate, not flux in the cell; the two diverge whenever substrate supply or allostery differs.

Part 6 — Failures That Recur

  • • Paralogs unmeasured in a knockout study of a multi-isoform enzyme.
  • • PKM knockout reported as PKM2 knockout.
  • • Nuclear function claimed from a knockout without a localisation-defective or catalytically dead control.
  • • LDHA phenotype attributed to lactate when redox or pyruvate supply explains it.
  • • Lysate activity reported as flux.
  • • Rescue construct not characterised for expression, localisation and stability.
  • • Single clone compared with parental at a different passage.
  • • Proliferation not measured, although biosynthetic demand sets the flux.

Part 7 — Where This Article Connects

This article sits under the pillar's partition-versus-rate distinction: each enzyme knockout changes a step, and whether that changes flux depends on control, which is distributed. The switch-level knockouts (PDK, MPC) are covered separately, as are the Seahorse protocols and the HK2-persistence troubleshooting article, which is written for the specific case where glycolysis survives the knockout.

If you need enzyme-level validation with paralog profiling and catalytic-dead rescue controls, we can scope the design with you.

Contact EDITGENE to request a project consultation or quote.

Scientific scope and validation note

Isoenzyme expression, mitochondrial association and isoform splicing vary by cell type and species; the expected directions here describe common patterns, not universal ones.

A knockout that leaves flux unchanged does not establish that the enzyme is dispensable, and a knockout that changes flux does not establish that the flux change caused the phenotype.

Scientific interpretation and experimental design

  • • Three reasons for no phenotype. Compensation, moonlighting, and non-limiting control.
  • • Measure the paralogs. The commonest review objection.
  • • PKM is not PKM2. Isoform-specific designs are required for isoform claims.
  • • LDHA is a redox enzyme. Pyruvate rescue separates carbon from redox.
  • • Catalytically dead rescue is the key control. Characterise it before interpreting it.
  • • Lysate activity is capacity, not flux.

Selected references for further reading

  • • Patra KC, et al. Hexokinase 2 is required for tumour initiation and maintenance. Cell Metabolism. 2013;18:698–711.
  • • Israelsen WJ, et al. PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells. Cell. 2013;155:397–409.
  • • Dayton TL, et al. Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma. Genes & Development. 2016;30:1020–1033.
  • • Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell. 2006;9:425–434.

Related Products

Product name Cat.No. Species Gene ID
PBRM1 Knockout A-549 Cell Line EDJ0001-K01 Human 55193 Details Get a Quote
YTHDC1 Knockout A-549 Cell Line EDC07652 Human 91746 Details Get a Quote
TP53 Knockout HCT 116 Cell Line EDC07854 Human 7157 Details Get a Quote
Sirt2 Knockout MH-S Cell Line EDJ-KQ78173 Mouse 64383 Details Get a Quote
TFE3 Knockout KGN Cell Line EDJ-KQ48 Human 7030 Details Get a Quote
Stub1 Knockout MB49 Cell Line EDJ-KQ53 Mouse 56424 Details Get a Quote
ARID1A Knockout SNK-6 Cell Line EDJ-KQ64 Human 8289 Details Get a Quote
Tet1 Knockout Kupffer Cell Line EDJ-KQ88 Mouse 52463 Details Get a Quote
NR1H3 Knockout HEK293T Cell Line EDJ-KQ109 Human 10062 Details Get a Quote
NR1H2 Knockout HEK293T Cell Line EDJ-KQ110 Human 7376 Details Get a Quote
RPS6KB2 Knockout HEK293 Cell Line EDJ-KQ125 Human 6199 Details Get a Quote
SMAD6 Knockout HEK293 Cell Line EDJ-KQ126 Human 4091 Details Get a Quote
JUN Knockout HEK293 Cell Line EDJ-KQ176 Human 3725 Details Get a Quote
JUN Knockout HEK293T Cell Line EDJ-KQ184 Human 3725 Details Get a Quote
ALKBH5 Knockout HEK293 Cell Line EDJ-KQ186 Human 54890 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: